+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pancreatic Cancer - Pipeline Review, H1 2020

  • ID: 5017448
  • Drug Pipelines
  • March 2020
  • Region: Global
  • 3802 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 4D Pharma Plc
  • Alligator Bioscience AB
  • Aposense Ltd
  • Beijing Syngentech Co Ltd
  • Cancer Advances Inc
  • Chiome Bioscience Inc
  • MORE
Pancreatic Cancer - Pipeline Review, H1 2020

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2020, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Pancreatic Cancer - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Pancreatic Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 19, 199, 207, 2, 8, 363, 57 and 9 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages comprises 25, 10, 3, 1, 63 and 11 molecules, respectively.

Pancreatic Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatic Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Pancreatic Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Pancreatic Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Pancreatic Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatic Cancer (Oncology)
Reasons to Buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Pancreatic Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Pancreatic Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 4D Pharma Plc
  • Alligator Bioscience AB
  • Aposense Ltd
  • Beijing Syngentech Co Ltd
  • Cancer Advances Inc
  • Chiome Bioscience Inc
  • MORE
  • Introduction
  • Pancreatic Cancer - Overview
  • Pancreatic Cancer - Therapeutics Development
  • Pancreatic Cancer - Therapeutics Assessment
  • Pancreatic Cancer - Companies Involved in Therapeutics Development
  • Pancreatic Cancer - Drug Profiles
  • Pancreatic Cancer - Dormant Projects
  • Pancreatic Cancer - Discontinued Products
  • Pancreatic Cancer - Product Development Milestones
  • Appendix
List of Tables
  • Number of Products under Development for Pancreatic Cancer, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020
  • Products under Development by Companies, H1 2020
  • Products under Development by Universities/Institutes, H1 2020
  • Number of Products by Stage and Target, H1 2020
  • Number of Products by Stage and Mechanism of Action, H1 2020
  • Number of Products by Stage and Route of Administration, H1 2020
  • Number of Products by Stage and Route of Administration, H1 2020 (Contd..1), H1 2020
  • Number of Products by Stage and Molecule Type, H1 2020
  • Number of Products by Stage and Molecule Type, H1 2020 (Contd..1), H1 2020
  • Pancreatic Cancer - Pipeline by 4D Pharma Plc, H1 2020
  • Pancreatic Cancer - Pipeline by 4SC AG, H1 2020
  • Pancreatic Cancer - Pipeline by A2 Biotherapeutics Inc, H1 2020
  • Pancreatic Cancer - Pipeline by AB Science SA, H1 2020
  • Pancreatic Cancer - Pipeline by AbbVie Inc, H1 2020
  • Pancreatic Cancer - Pipeline by AbClon Inc, H1 2020
  • Pancreatic Cancer - Pipeline by AbGenomics International Inc, H1 2020
  • Pancreatic Cancer - Pipeline by Ability Pharmaceuticals SL, H1 2020
  • Pancreatic Cancer - Pipeline by Accendatech Co Ltd, H1 2020
  • Pancreatic Cancer - Pipeline by Accuronix Therapeutics Inc, H1 2020
  • Pancreatic Cancer - Pipeline by ACF Pharmaceuticals LLC, H1 2020
  • Pancreatic Cancer - Dormant Projects, H1 2020
  • Pancreatic Cancer - Discontinued Products, H1 2020
List of Figures
  • Number of Products under Development for Pancreatic Cancer, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020
  • Number of Products by Top 10 Targets, H1 2020
  • Number of Products by Stage and Top 10 Targets, H1 2020
  • Number of Products by Top 10 Mechanism of Actions, H1 2020
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
  • Number of Products by Top 10 Routes of Administration, H1 2020
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2020
  • Number of Products by Top 10 Molecule Types, H1 2020
  • Number of Products by Stage and Top 10 Molecule Types, H1 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • 4D Pharma Plc
  • 4SC AG
  • A2 Biotherapeutics Inc
  • AB Science SA
  • AbbVie Inc
  • AbClon Inc
  • AbGenomics International Inc
  • Ability Pharmaceuticals SL
  • Accendatech Co Ltd
  • Accuronix Therapeutics Inc
  • ACF Pharmaceuticals LLC
  • Aclaris Therapeutics Inc
  • Actuate Therapeutics Inc
  • Adamed Sp zoo
  • ADC Therapeutics SA
  • Adlai Nortye Biopharma Co Ltd
  • Aduro BioTech Inc
  • Advanced BioDesign
  • Advanced Cancer Therapeutics LLC
  • Advanz Pharmaceutical Corp Ltd
  • Advenchen Laboratories LLC
  • Affimed GmbH
  • Agency for Science, Technology and Research
  • Agios Pharmaceuticals Inc
  • AGV Discovery SAS
  • AIM ImmunoTech Inc
  • Alissa Pharma
  • Alligator Bioscience AB
  • Allinky Biopharma SL
  • Almac Discovery Ltd
  • Alphamab Oncology
  • Altor Bioscience LLC
  • ALX Oncology Inc
  • Ambrx Inc
  • amcure GmbH
  • Amgen Inc
  • Amphera BV
  • Amplia Therapeutics Ltd
  • Anavex Life Sciences Corp
  • Andarix Pharmaceuticals Inc
  • Andes Biotechnologies
  • ANP Technologies Inc
  • Antapodia Therapeutics Inc
  • AntiCancer Inc
  • APEIRON Biologics AG
  • Apexian Pharmaceuticals Inc
  • Apexigen Inc
  • Aphios Corp
  • Apollomics Inc
  • Aposense Ltd
  • Aravive Inc
  • Arbele Ltd
  • Arcus Biosciences Inc
  • Argonaut Therapeutics Ltd
  • Asana BioSciences LLC
  • Ascelia Pharma AB
  • Ascenta Therapeutics Inc
  • Ascentage Pharma Group International
  • Ascentawits Pharmaceuticals Ltd
  • Asclepiumm Taiwan Co Ltd
  • Asclepius Technology Company Group Suzhou Co Ltd
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Augustus BioTarget Inc
  • AUM Biosciences Pte Ltd
  • Aurigene Discovery Technologies Ltd
  • Avenzoar Pharmaceuticals Inc
  • AVEO Oncology Inc
  • Avican Inc
  • Basilea Pharmaceutica Ltd
  • Bausch Health Companies Inc
  • Bavarian Nordic A/S
  • Bayer AG
  • BeiGene Ltd
  • Beijing Syngentech Co Ltd
  • Bellicum Pharmaceuticals Inc
  • Benhealth Biopharmaceutical (Shenzhen) Co Ltd
  • Berg LLC
  • BerGenBio ASA
  • Bessor Pharma LLC
  • Bexion Pharmaceuticals LLC
  • BeyondBio Inc
  • BeyondSpring Inc
  • Bio-Path Holdings Inc
  • BioAtla LLC
  • Biokine Therapeutics Ltd
  • BioLineRx Ltd
  • BioMed Valley Discoveries Inc
  • BioMoti Ltd
  • Biomunex Pharmaceuticals
  • BioNTech SE
  • Biothera Pharmaceutical Inc
  • BioTheryX Inc
  • BioXcel Therapeutics Inc
  • BJ Bioscience Inc
  • BLR Bio LLC
  • Boehringer Ingelheim International GmbH
  • Boston Biomedical Inc
  • BriaCell Therapeutics Corp
  • Bristol-Myers Squibb Co
  • Calidi Biotherapeutics Inc
  • Cancer Advances Inc
  • Cancer Prevention Pharmaceuticals Inc
  • Cancer Vaccines Ltd
  • Candel Therapeutics
  • Canget BioTekpharma LLC
  • Cannabis Science Inc
  • Cantargia AB
  • Cantex Pharmaceuticals Inc
  • CARsgen Therapeutics Ltd
  • Cascade Prodrug Inc
  • Cassiopea SpA
  • CCRP Therapeutics GmbH
  • Celldex Therapeutics Inc
  • Celleron Therapeutics Ltd
  • Cellivery Therapeutics Inc
  • Cello Therapeutics Inc
  • Celprogen Inc
  • Celyad SA
  • Cend Therapeutics Inc
  • Centrose LLC
  • ChemoCentryx Inc
  • Chimeric Therapeutics Ltd
  • Chiome Bioscience Inc
  • CHO Pharma Inc
  • Cloaked Therapeutics LLC
  • Clovis Oncology Inc
  • CLS Therapeutics
  • CNS Pharmaceuticals Inc
  • COARE Biotechnology Inc
  • COARE Holdings Inc
  • Codiak BioSciences Inc
  • Coherent Biopharma
  • Collaborative Medicinal Development LLC
  • Convalife
  • Convert Pharmaceuticals SA
  • Corcept Therapeutics Inc
  • Corvus Pharmaceuticals Inc
  • Cotinga Pharmaceuticals Inc
  • Counterpoint Biomedica LLC
  • CPL Biologicals Pvt Ltd
  • CrystalGenomics Inc
  • Cumberland Pharmaceuticals Inc
  • Curegenix Inc
  • CureLab Oncology Inc
  • CureMeta LLC
  • Cyclacel Pharmaceuticals Inc
  • Cyteir Therapeutics Inc
  • CytImmune Sciences Inc
  • Cytocom Inc
  • Cytodyn Inc
Note: Product cover images may vary from those shown
Adroll
adroll